Therefore, NMO should be considered and serum AQP4 Ab levels should be tested in MG patients with clinical signs or symptoms indicative of NMO; these include spinal cord and optic neuropathy, and brainstem symptoms such as intractable vomiting, narcolepsy or hiccoughs. This evidence concerns the gene AQP4 and myasthenia gravis.